List of Tables
Table 1. Global Osteoporosis Injections Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Osteoporosis Injections Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Osteoporosis Injections Market Competitive Situation by Manufacturers in 2025
Table 4. Global Osteoporosis Injections Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Osteoporosis Injections Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Osteoporosis Injections Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Osteoporosis Injections Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Osteoporosis Injections Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Osteoporosis Injections, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Osteoporosis Injections, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Osteoporosis Injections, Product Types and Applications
Table 12. Global Key Manufacturers of Osteoporosis Injections, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Osteoporosis Injections Companies by Tier (Tier 1, Tier 2, Tier 3), based on Osteoporosis Injections Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Osteoporosis Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Osteoporosis Injections Sales by Region (K Dose), 2021–2026
Table 18. Global Osteoporosis Injections Sales Market Share by Region (2021–2026)
Table 19. Global Osteoporosis Injections Sales by Region (K Dose), 2027–2032
Table 20. Global Osteoporosis Injections Sales Market Share by Region (2027–2032)
Table 21. Global Osteoporosis Injections Revenue by Region (US$ Million), 2021–2026
Table 22. Global Osteoporosis Injections Revenue Market Share by Region (2021–2026)
Table 23. Global Osteoporosis Injections Revenue by Region (US$ Million), 2027–2032
Table 24. Global Osteoporosis Injections Revenue Market Share by Region (2027–2032)
Table 25. North America Osteoporosis Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Osteoporosis Injections Sales by Country (K Dose), 2021–2026
Table 27. North America Osteoporosis Injections Sales by Country (K Dose), 2027–2032
Table 28. North America Osteoporosis Injections Revenue by Country (US$ Million), 2021–2026
Table 29. North America Osteoporosis Injections Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Osteoporosis Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Osteoporosis Injections Sales by Country (K Dose), 2021–2026
Table 32. Europe Osteoporosis Injections Sales by Country (K Dose), 2027–2032
Table 33. Europe Osteoporosis Injections Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Osteoporosis Injections Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Osteoporosis Injections Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Osteoporosis Injections Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Osteoporosis Injections Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Osteoporosis Injections Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Osteoporosis Injections Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Osteoporosis Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Osteoporosis Injections Sales by Country (K Dose), 2021–2026
Table 42. Latin America Osteoporosis Injections Sales by Country (K Dose), 2027–2032
Table 43. Latin America Osteoporosis Injections Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Osteoporosis Injections Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Osteoporosis Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Osteoporosis Injections Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Osteoporosis Injections Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Osteoporosis Injections Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Osteoporosis Injections Revenue by Country (US$ Million), 2027–2032
Table 50. Global Osteoporosis Injections Sales (K Dose) by Type (2021–2026)
Table 51. Global Osteoporosis Injections Sales (K Dose) by Type (2027–2032)
Table 52. Global Osteoporosis Injections Sales Market Share by Type (2021–2026)
Table 53. Global Osteoporosis Injections Sales Market Share by Type (2027–2032)
Table 54. Global Osteoporosis Injections Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Osteoporosis Injections Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Osteoporosis Injections Revenue Market Share by Type (2021–2026)
Table 57. Global Osteoporosis Injections Revenue Market Share by Type (2027–2032)
Table 58. Global Osteoporosis Injections Price (US$/Dose) by Type (2021–2026)
Table 59. Global Osteoporosis Injections Price (US$/Dose) by Type (2027–2032)
Table 60. Global Osteoporosis Injections Sales (K Dose) by Application (2021–2026)
Table 61. Global Osteoporosis Injections Sales (K Dose) by Application (2027–2032)
Table 62. Global Osteoporosis Injections Sales Market Share by Application (2021–2026)
Table 63. Global Osteoporosis Injections Sales Market Share by Application (2027–2032)
Table 64. Global Osteoporosis Injections Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Osteoporosis Injections Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Osteoporosis Injections Revenue Market Share by Application (2021–2026)
Table 67. Global Osteoporosis Injections Revenue Market Share by Application (2027–2032)
Table 68. Global Osteoporosis Injections Price (US$/Dose) by Application (2021–2026)
Table 69. Global Osteoporosis Injections Price (US$/Dose) by Application (2027–2032)
Table 70. Eli Lilly Company Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Eli Lilly Osteoporosis Injections Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. Amgen Osteoporosis Injections Product
Table 79. Amgen Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Novartis Osteoporosis Injections Product
Table 84. Novartis Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Pfizer Osteoporosis Injections Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Radius Health Company Information
Table 91. Radius Health Description and Business Overview
Table 92. Radius Health Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Radius Health Osteoporosis Injections Product
Table 94. Radius Health Recent Developments/Updates
Table 95. Asahi Kasei Pharma Company Information
Table 96. Asahi Kasei Pharma Description and Business Overview
Table 97. Asahi Kasei Pharma Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Asahi Kasei Pharma Osteoporosis Injections Product
Table 99. Asahi Kasei Pharma Recent Developments/Updates
Table 100. Pharmanovia Company Information
Table 101. Pharmanovia Description and Business Overview
Table 102. Pharmanovia Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Pharmanovia Osteoporosis Injections Product
Table 104. Pharmanovia Recent Developments/Updates
Table 105. Alvogen Company Information
Table 106. Alvogen Description and Business Overview
Table 107. Alvogen Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Alvogen Osteoporosis Injections Product
Table 109. Alvogen Recent Developments/Updates
Table 110. Shenzhen Salubris Pharmaceuticals Company Information
Table 111. Shenzhen Salubris Pharmaceuticals Description and Business Overview
Table 112. Shenzhen Salubris Pharmaceuticals Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Shenzhen Salubris Pharmaceuticals Osteoporosis Injections Product
Table 114. Shenzhen Salubris Pharmaceuticals Recent Developments/Updates
Table 115. Shanghai United Cell Biotechnology Company Information
Table 116. Shanghai United Cell Biotechnology Description and Business Overview
Table 117. Shanghai United Cell Biotechnology Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Shanghai United Cell Biotechnology Osteoporosis Injections Product
Table 119. Shanghai United Cell Biotechnology Recent Developments/Updates
Table 120. Qilu Pharmaceutical Company Information
Table 121. Qilu Pharmaceutical Description and Business Overview
Table 122. Qilu Pharmaceutical Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. Qilu Pharmaceutical Osteoporosis Injections Product
Table 124. Qilu Pharmaceutical Recent Developments/Updates
Table 125. Chengdu Easton Biopharmaceuticals Company Information
Table 126. Chengdu Easton Biopharmaceuticals Description and Business Overview
Table 127. Chengdu Easton Biopharmaceuticals Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 128. Chengdu Easton Biopharmaceuticals Osteoporosis Injections Product
Table 129. Chengdu Easton Biopharmaceuticals Recent Developments/Updates
Table 130. Hunan Fangsheng Pharmaceutical Company Information
Table 131. Hunan Fangsheng Pharmaceutical Description and Business Overview
Table 132. Hunan Fangsheng Pharmaceutical Osteoporosis Injections Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 133. Hunan Fangsheng Pharmaceutical Osteoporosis Injections Product
Table 134. Hunan Fangsheng Pharmaceutical Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Osteoporosis Injections Distributors List
Table 138. Osteoporosis Injections Customers List
Table 139. Osteoporosis Injections Market Trends
Table 140. Osteoporosis Injections Market Drivers
Table 141. Osteoporosis Injections Market Challenges
Table 142. Osteoporosis Injections Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Osteoporosis Injections
Figure 2. Global Osteoporosis Injections Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Osteoporosis Injections Market Share by Type: 2025 & 2032
Figure 4. Bone Resorption Inhibitors Product Picture
Figure 5. Bone Formation Promoters Product Picture
Figure 6. Global Osteoporosis Injections Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Osteoporosis Injections Market Share by Application: 2025 & 2032
Figure 8. Female
Figure 9. Male
Figure 10. Global Osteoporosis Injections Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Osteoporosis Injections Market Size (US$ Million), 2021–2032
Figure 12. Global Osteoporosis Injections Sales (K Dose), 2021–2032
Figure 13. Global Osteoporosis Injections Average Price (US$/Dose), 2021–2032
Figure 14. Osteoporosis Injections Report Years Considered
Figure 15. Osteoporosis Injections Sales Share by Manufacturers in 2025
Figure 16. Global Osteoporosis Injections Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Osteoporosis Injections Players: Market Share by Revenue in Osteoporosis Injections in 2025
Figure 18. Osteoporosis Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Osteoporosis Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Osteoporosis Injections Sales Market Share by Country (2021–2032)
Figure 21. North America Osteoporosis Injections Revenue Market Share by Country (2021–2032)
Figure 22. United States Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Osteoporosis Injections Sales Market Share by Country (2021–2032)
Figure 25. Europe Osteoporosis Injections Revenue Market Share by Country (2021–2032)
Figure 26. Germany Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Osteoporosis Injections Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Osteoporosis Injections Revenue Market Share by Region (2021–2032)
Figure 33. China Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. China Taiwan Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Southeast Asia Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Latin America Osteoporosis Injections Sales Market Share by Country (2021–2032)
Figure 41. Latin America Osteoporosis Injections Revenue Market Share by Country (2021–2032)
Figure 42. Mexico Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Brazil Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Argentina Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Colombia Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Middle East and Africa Osteoporosis Injections Sales Market Share by Country (2021–2032)
Figure 47. Middle East and Africa Osteoporosis Injections Revenue Market Share by Country (2021–2032)
Figure 48. Turkey Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Saudi Arabia Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. UAE Osteoporosis Injections Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Global Sales Market Share of Osteoporosis Injections by Type (2021–2032)
Figure 52. Global Revenue Market Share of Osteoporosis Injections by Type (2021–2032)
Figure 53. Global Osteoporosis Injections Price (US$/Dose) by Type (2021–2032)
Figure 54. Global Sales Market Share of Osteoporosis Injections by Application (2021–2032)
Figure 55. Global Revenue Market Share of Osteoporosis Injections by Application (2021–2032)
Figure 56. Global Osteoporosis Injections Price (US$/Dose) by Application (2021–2032)
Figure 57. Osteoporosis Injections Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
